Improved method for analysis of cysteinyldopa in human serum
Authors:
- 1 October 2004
- journal article
- case report
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 64 (6) , 559-564
Abstract
5‐S‐l‐Cysteinyl‐l‐dopa is a well‐known pigment intermediate and analysis of its serum concentration is well suited for evaluation of treatment and follow‐up of stage III and IV malignant melanoma. A simplified analytical method is described using organic extraction followed by clean‐up on a boronate gel to capture the compound containing vicinal hydroxyls. Weak acid solution elutes the 5‐S‐cysteinyldopa suitable for high‐performance liquid chromatography (HPLC). The absolute recoveries of cysteinyldopa and its diastereomer 5‐S‐D‐cysteinyl‐l‐dopa (used as an internal standard) were 81.5±2.8% and 81.3±2.7%, respectively, and use of the internal standard for the whole procedure gave an analytical recovery of 101±0.8%. The limit of quantitation was 1.5 nmol/L and the imprecision of the method was <5.0% over the analytical range 1.5–500 nmol/L. The method is cheap and easy to perform and compares well with other described techniques. The use of the method is illustrated by results obtained during treatment of a patient with metastatic malignant melanoma.Keywords
This publication has 11 references indexed in Scilit:
- Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanomaEuropean Journal of Cancer, 2003
- Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III–IV malignant melanomaPathology and Oncology Research, 2002
- Serum concentration of 5‐S‐cysteinyldopa in patients with melanomaEuropean Journal of Clinical Investigation, 2000
- The value of cysteinyldopa in the follow-up of disseminated malignant melanomaMelanoma Research, 2000
- S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5- methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanomaMelanoma Research, 1997
- Serum 5‐S‐Cysteinyldopa (5‐S‐CD) as a Marker of Melanoma ProgressionThe Journal of Dermatology, 1992
- Automated high-performance liquid chromatographic determination of 5-S-cysteinyl-3,4-dihydroxyphenylalanine in urineJournal of Chromatography A, 1989
- Liquid-chromatographic determination of 5-S-L-cysteinyl-L-dopa with electrochemical detection in urine prepurified with a phenylboronate affinity gel.Clinical Chemistry, 1983
- Diastereomers of 5-S-cysteinyldopaActa Dermato-Venereologica, 1983
- Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatographic analysisJournal of Chromatography B: Biomedical Sciences and Applications, 1981